Home > Healthcare > Pharmaceuticals > Finished Drug Form > Antidepressant Drugs Market

Antidepressant Drugs Market Size

Report ID: GMI2505
Published Date: Sep 2021
Report Format: PDF

Download Free Sample

Antidepressant Drugs Market Size

Antidepressant Drugs Market size exceeded USD 13.5 billion in 2020 and is anticipated to grow at over 7.2% CAGR between 2021 and 2027. Broader accessibility with number of available products in the market will significantly boost the product sales, thus benefiting the overall industry growth.

Antidepressant Drugs Market Overview

To get key market trends

Download Free Sample

Supportive government initiatives to broaden accessibility of basic treatment for all mental health conditions will favour the market expansion. For instance, the European Commission launched RECOVER-E project under Horizon-2020 in 2018 for implementation of mental health service delivery model to improve mental health of population in Europe. Additionally, the Government of India proposed budget of more than USD 80 million for mental healthcare in its union budget for 2021-2022.

Antidepressant Drugs Market Report Attributes
Report Attribute	Details
Base Year:	2020
Antidepressant Drugs Market Size in 2020:	13.7 Billion (USD)
Forecast Period:	2021 to 2027
Forecast Period 2021 to 2027 CAGR:	7.2%
2027 Value Projection:	22.5 Billion (USD)
Historical Data for:	2016 to 2020
No. of Pages:	120
Tables, Charts & Figures:	148
Segments covered:	Drug Class, Application, and Region
Growth Drivers:	Rising prevalence of depression and anxiety disorders Increasing investment in research and development Growing awareness regarding treatment therapies and mental health
Pitfalls & Challenges:	Side effects associated with some antidepressant drugs Customer preference for non-pharmacological therapeutics over pharmacological therapeutics

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size of antidepressant drugs was over USD 13.5 billion during 2020 and is expected to witness around 7.2% CAGR up to 2027 with increased access to a large number of products.

Serotonin-norepinephrine reuptake inhibitors (SNRIs) class of drugs held nearly 9% of global antidepressant drugs industry share in 2020 and will grow due to increasing cases of depression and anxiety disorders.

The key types of antidepressant drugs include Serotonin-norepinephrine Reuptake Inhibitors (SNRIs), Selective Serotonin Reuptake Inhibitors {SSRIs} and Tricyclic Antidepressants.

Europe market held more than 25% of revenue share in 2020 and will expand with rising awareness and acceptance of mental disorders and related therapies.

Leading antidepressant drug manufacturers worldwide include Novartis, GlaxoSmithKline, Pfizer, Eli Lilly & Company, Janssen Pharmaceuticals, Bristol-Myers Squibb, Sandoz Inc., Otsuka Pharmaceutical and Sun Pharmaceuticals, among some others.